Omalizumab in Chronic Spontaneous Urticaria (CSU): Real-Life Experience in Dose/Interval Adjustments and Treatment Discontinuation奥马珠单抗治疗慢性自发性荨麻疹 (CSU): 剂量/间隔调整和治疗停药的现实经验JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICEIF6.62023-08-019PRE
Cold Urticaria. Characterizing the population From an Urticaria Outpatient Clinic寒冷性荨麻疹。从荨麻疹门诊诊所表征人群ACTAS DERMO-SIFILIOGRAFICASIF2.82021-09-015OAAI
Contribution of In Vivo and In Vitro Testing for The Diagnosis of Local Allergic RhinitisJOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGYIF4.82019-02-1917OAAI
Expansion of FOXP3+ regulatory CD4 T cells upon exposure to hymenoptera venom during the beekeeping seasonALLERGYIF122019-01-178PREAI
Treatment of Severe Atopic Dermatitis with Omalizumab: Experience of a Portuguese Immunoallergology DepartmentJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-011OAAI
Omalizumab and Severe Alergic Asthma : Assessment after 1 Year of TreatmentJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22016-02-010OAAI
Monocyte activation is a feature of common variable immunodeficiency irrespective of plasma lipopolysaccharide levelsCLINICAL AND EXPERIMENTAL IMMUNOLOGYIF3.82012-08-0247OA
Omalizumab - One Year Experience In The Treatment Of Severe Atopic DermatitisJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22012-02-011PRE
Treating Chronic Urticaria With Omalizumab - Our Experience In An Immunoallergology DepartmentJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22012-02-010PRE
Expansion of circulating Foxp3+CD25bright CD4+ T cells during specific venom immunotherapyCLINICAL AND EXPERIMENTAL ALLERGYIF5.22007-12-0774PREAI
Tropomyosin: Is it responsible for the cross-reactivity crustaceans-dust mitesJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22006-02-010OA
Safety of sublingual latex immunotherapy. Are specific IgE to recombinant latex allergens a risk factor?JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22006-02-010PRE
Soluble adhesion molecules:: Therapeutic target for allergen immunotherapyJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22002-01-010OAAI
Adverse drug reaction diagnosis by cellular antigen stimulation test (CAST-ELISA):: Correlation with oral drug challengeJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22002-01-010PRE
Evaluation of the immunotherapy efficacy by immunoblotting methodsJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22002-01-011OAAI
Latex and chickpea (Cicer arietinum) allergy:: First description of a new associationJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22002-01-010OAAI
Diagnostic methodology in analgesic/anti-inflammatory drugs hypersensitivityJOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGYIF11.22002-01-010PRE